OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PYPD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYPD is expected to report earnings to fall 27.86% to -50 cents per share on August 06

Q2'25

Est.

$-0.50

Q1'25

Beat

by $0.22

Q4'24

Missed

by $0.22

Q3'24

Missed

by $0.22

Q2'24

Beat

by $0.05

The last earnings report on May 14 showed earnings per share of -69 cents, beating the estimate of -92 cents. With 11.38K shares outstanding, the current market capitalization sits at 28.43M.

View a ticker or compare two or three

Compare

PYPD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PYPD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

18 Hasivim Street

Phone

+972 747195700

Employees

Web

https://www.polypid.com